Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4541084
Max Phase: Preclinical
Molecular Formula: C33H38N8O4
Molecular Weight: 610.72
Molecule Type: Unknown
Associated Items:
ID: ALA4541084
Max Phase: Preclinical
Molecular Formula: C33H38N8O4
Molecular Weight: 610.72
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1ccc(-c2ccc(C[C@H](NC(=O)[C@H]3CC[C@H](CN)CC3)C(=O)Nc3ccc(-c4nn[nH]n4)cc3)cc2)c(C)n1
Standard InChI: InChI=1S/C33H38N8O4/c1-3-45-33(44)28-17-16-27(20(2)35-28)23-8-4-21(5-9-23)18-29(37-31(42)25-10-6-22(19-34)7-11-25)32(43)36-26-14-12-24(13-15-26)30-38-40-41-39-30/h4-5,8-9,12-17,22,25,29H,3,6-7,10-11,18-19,34H2,1-2H3,(H,36,43)(H,37,42)(H,38,39,40,41)/t22-,25-,29-/m0/s1
Standard InChI Key: MVYPPJBYNQHFFT-HTLVZCCDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 610.72 | Molecular Weight (Monoisotopic): 610.3016 | AlogP: 3.84 | #Rotatable Bonds: 11 |
Polar Surface Area: 177.87 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 5.94 | CX Basic pKa: 10.22 | CX LogP: 2.62 | CX LogD: 2.61 |
Aromatic Rings: 4 | Heavy Atoms: 45 | QED Weighted: 0.18 | Np Likeness Score: -1.10 |
1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA.. (2020) Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding., 63 (4): [PMID:31658420] [10.1021/acs.jmedchem.9b01060] |
Source(1):